System Type Segment Analysis: Portable (Largest & Fastest-Growing Segment)

Portable systems dominated the gas exchange pulmonary function testing market, accounting for 81.14% in 2026, while also representing the fastest-growing system type. Their strong position is supported by the growing need for flexible pulmonary testing across hospitals, outpatient facilities, diagnostic settings, and other care environments. Portable systems can facilitate testing closer to the patient and support decentralized healthcare delivery, making them valuable where mobility and efficient use of clinical space are important. Increasing demand for accessible respiratory assessment, advances in compact diagnostic technologies, and the broader shift toward more flexible healthcare services are expected to sustain the growth of portable gas exchange pulmonary function testing systems.

Test Method Segment Analysis: Gas Diffusion Tests (Largest Segment) vs Cardiopulmonary Exercise Testing (CPET) (Fastest-Growing Segment)

Gas diffusion tests held the largest share of the gas exchange pulmonary function testing market, representing 58.56% in 2026. These tests are important for assessing how effectively gases move between the lungs and bloodstream, providing valuable information for the evaluation of respiratory function and pulmonary disorders. Their established role in routine respiratory assessment and their ability to support the diagnosis and monitoring of conditions affecting gas transfer contribute to their widespread use. Growing awareness of respiratory health and the increasing need for objective pulmonary evaluation continue to support the segment's leading position.

Cardiopulmonary exercise testing (CPET) is expected to be the fastest-growing test method as healthcare providers increasingly seek comprehensive assessments of cardiopulmonary performance under physical stress. CPET evaluates the integrated response of the respiratory, cardiovascular, and metabolic systems, providing insights that may not be captured through resting assessments alone. Its expanding role in evaluating unexplained exercise intolerance, functional capacity, and complex cardiopulmonary conditions is expected to drive greater adoption. The growing emphasis on personalized diagnosis and more comprehensive functional evaluation further supports demand for CPET.

End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Diagnostic Centers (Fastest-Growing Segment)

Hospitals & clinics accounted for the largest share of the gas exchange pulmonary function testing market, capturing 59.9% in 2026. These facilities serve as major centers for respiratory diagnosis, treatment planning, and long-term disease management, creating sustained demand for pulmonary function testing systems. The availability of specialized healthcare professionals, integrated diagnostic infrastructure, and access to patients with complex respiratory conditions supports the widespread use of gas exchange testing in hospitals and clinics. Rising respiratory disease burden and increasing emphasis on early and accurate diagnosis are expected to maintain the segment's strong position.

Diagnostic centers are projected to be the fastest-growing end-use segment as healthcare systems increasingly rely on specialized facilities to expand access to diagnostic testing. Dedicated diagnostic centers can provide focused pulmonary assessment, efficient testing workflows, and greater convenience for patients outside traditional hospital environments. The growing trend toward outpatient care, increasing demand for timely diagnostic services, and the expansion of specialized testing infrastructure are expected to support greater adoption of gas exchange pulmonary function testing in diagnostic centers.